NCT07016243 Correlation Between Deficits in Knee ROM Recovery and Difficulty in Dorsiflexing the Tibio-tarsal Joint in Patients Undergoing Total Knee Replacement Surgery.
| NCT ID | NCT07016243 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Articulation Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 197 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 197 participants in total. It began in 2025-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To demonstrate that the deficit in dorsiflexion-tibia-talar joint range of motion can have an effect on the knee operated by arthroplasty by limiting full extension and, in general, the recovery of a full range of motion.
Eligibility Criteria
Inclusion Criteria:• * Patients who are candidates for primary total knee replacement surgery aged 65 to 85 years; * Patients who have provided informed consent Exclusion Criteria:• * Patients with known neurological pathologies * Severe joint deformations such as previous ankle surgery (arthrodesis, ankle prosthesis) congenital malformations (cavus equinus, clubfoot) * Severe fractures that have compromised the joint * Traumatic events affecting the lower limb that occurred less than 12 months * Non-ambulatory patients in the preoperative period
Contact & Investigator
Laura Tornatore
PRINCIPAL INVESTIGATOR
Istituto Ortopedico Rizzoli - Dipartimento Sicilia
Frequently Asked Questions
Who can join the NCT07016243 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 85 Years, studying Articulation Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07016243 currently recruiting?
Yes, NCT07016243 is actively recruiting participants. Contact the research team at laura.tornatore@ior.it for enrollment information.
Where is the NCT07016243 trial being conducted?
This trial is being conducted at Bagheria, Italy.
Who is sponsoring the NCT07016243 clinical trial?
NCT07016243 is sponsored by Istituto Ortopedico Rizzoli. The principal investigator is Laura Tornatore at Istituto Ortopedico Rizzoli - Dipartimento Sicilia. The trial plans to enroll 197 participants.